ArticleBMC cancer2020

Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report.

Yuta Adachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.